EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular and Clinical Characterization of Invasive Streptococcus pyogenes Isolates: Insights from Two Northern-Italy Centers

Carmelo Bonomo iD, Eva Mannino, Dafne Bongiorno iD, Caterina Vocale, Armando Amicucci, Dalida Bivona, Davide Guariglia, Emanuele Nicitra iD, Grete Francesca Privitera iD, Giuseppe Sangiorgio iD, Stefania Stefani iD, Simone Ambretti iD

Pathogens · 2025

DOI: 10.3390/pathogens14020152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Carmelo Bonomo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95124 Catania, Italy. Hauptthemen laut MEDLINE: Streptococcus pyogenes, Streptococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PON Ricerca e Innovazione 2014–2020, MUR PNRR Extended Partnership Initiative on Emerging Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus pyogenes (Group A Streptococcus, GAS) is a Gram-positive pathogen responsible for both superficial and invasive infections (iGAS), with increasing global incidence in recent years. This study aims to characterize the molecular and clinical features of iGAS cases in Bologna and Imola (Italy) between 2022 and 2024. Thirty-five invasive isolates were analyzed through whole-genome sequencing (WGS) to investigate the distribution of emm types, antimicrobial resistance (AMR) genes, and virulence factors. Clinical and epidemiological data were retrospectively collected and analyzed. The majority of cases (80%) were recorded in 2023, predominantly among patients aged over 65 (60%). Bloodstream infections were present in 97.1% of cases, and comorbidities such as diabetes and immunosuppression were common. Empirical antibiotic therapy often involved penicillin/β-lactam inhibitors, while oxazolidinones were the most frequently used in targeted regimens. The in-hospital mortality rate was 20%. Genomic analysis identified emm1, emm12, and emm89 as the most prevalent types, associated with specific virulence profiles and resistance determinants. This study highlights the critical role of emm typing and genomic characterization in understanding the pathogenicity of GAS. These findings contribute to the identification of risk factors for severe outcomes and underscore the need for targeted prevention and treatment strategies in vulnerable populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pyogenesStreptococcal InfectionsHumansItalyMaleFemaleAgedMiddle AgedAnti-Bacterial AgentsVirulence FactorsAdultRetrospective StudiesWhole Genome SequencingAged, 80 and overDrug Resistance, BacterialChildBacterial Outer Membrane ProteinsChild, PreschoolAdolescentYoung AdultAntigens, BacterialCarrier Proteins

Stichwörter der Autor:innen

Streptococcus pyogenesinvasive group A Streptococcus (iGAS)whole genome sequencing (WGS)

Substanzen

Anti-Bacterial AgentsVirulence FactorsBacterial Outer Membrane ProteinsAntigens, BacterialCarrier Proteins

Autor:innen und Institutionen

  • Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, 95124 Catania, Italy.
  • Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
  • Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Department of Medical and Surgical Sciences, Section of Microbiology, University of Bologna, 40136 Bologna, Italy.
  • Department of Clinical and Experimental Medicine, Department of Mathematical and Computational Science, University of Catania, 95124 Catania, Italy.

ORCID-Profile: Carmelo Bonomo, Dafne Bongiorno, Emanuele Nicitra, Grete Francesca Privitera, Giuseppe Sangiorgio, Stefania Stefani, Simone Ambretti

Förderung

  • PON Ricerca e Innovazione 2014–2020
  • MUR PNRR Extended Partnership Initiative on Emerging Infectious Diseases

Zitieren

APA

Bonomo, C., Mannino, E., Bongiorno, D., Vocale, C., Amicucci, A., Bivona, D., Guariglia, D., Nicitra, E., Privitera, G. F., Sangiorgio, G., Stefani, S., & Ambretti, S. (2025). Molecular and Clinical Characterization of Invasive Streptococcus pyogenes Isolates: Insights from Two Northern-Italy Centers. Pathogens. https://doi.org/10.3390/pathogens14020152

Vancouver

Bonomo C, Mannino E, Bongiorno D, Vocale C, Amicucci A, Bivona D, et al. Molecular and Clinical Characterization of Invasive Streptococcus pyogenes Isolates: Insights from Two Northern-Italy Centers. Pathogens. 2025. doi:10.3390/pathogens14020152

BibTeX
@article{Bonomo2025,
  author = {Bonomo, Carmelo and Mannino, Eva and Bongiorno, Dafne and Vocale, Caterina and Amicucci, Armando and Bivona, Dalida and Guariglia, Davide and Nicitra, Emanuele and Privitera, Grete Francesca and Sangiorgio, Giuseppe and Stefani, Stefania and Ambretti, Simone},
  title = {Molecular and Clinical Characterization of Invasive Streptococcus pyogenes Isolates: Insights from Two Northern-Italy Centers},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14020152}
}
Kostenlos starten →